• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD. GELWEAVE; GELWEAVE PLEXUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD. GELWEAVE; GELWEAVE PLEXUS Back to Search Results
Model Number PLEXUS
Device Problems Use of Device Problem (1670); Device Handling Problem (3265)
Patient Problems Aneurysm (1708); Aortic Dissection (2491)
Event Date 06/23/2020
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Communication/interviews - from further questioning it was indicated that the device was not pre-soaked in saline or any other medium prior to use as recommended in ifu cautions.A 5-year review of previous similar events for gelweave graft gave an occurrence rate of (b)(4) (complaints v sales).A review of qc and manufacturing records showed that the batch was manufactured to design specification.All testing including physical test of base material met all acceptance criteria - all pre-release leakage testing was well within product acceptance criteria.No additional reports of leakage were received for any other devices in this batch.Vascutek now considers this complaint closed.Further action is not planned, however, the issue will be tracked and trended as part of the on-going complaints trending and reporting process and if an adverse trend develops action may be taken at that time.
 
Event Description
Patient admitted for acute type a dissection debakey type i based on a pre-existing ascending aneurysm, no anticoagulation treatment in medical history, emergent arch replacement.Patient underwent aortic arch replacement under hypothermic circulatory arrest (25 °c) and bilateral antegrade cerebral perfusion.After weaning from cardiopulmonary bypass and adequate substitution of protamine, progressive leakage of prosthesis in the area of first side branch of plexus prosthesis and along black suture mark of main body.Clinical relevant blood loss, despite massive substitution of fibrinogen, thrombocytes, protamine, desmopressin and fresh frozen plasma no improvement of leakage over three hours.Additional local fibrin glue and other hemostyptic material applied on top of prosthetic material.After wound closure no relevant bleeding, patient is extubated and clinical stable.Patient received massive substitution of blood and coagulation products but tolerated all very well.Operative time was prolonged but patient recovered uneventful.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GELWEAVE
Type of Device
GELWEAVE PLEXUS
Manufacturer (Section D)
VASCUTEK LTD.
newmains avenue
inchinnan business park
renfrewshire, PA4 9 RR
UK  PA4 9RR
Manufacturer (Section G)
VASCUTEK LTD.
newmains avenue
inchinnan business park
renfrewshire, PA4 9 RR
UK   PA4 9RR
Manufacturer Contact
jason whittle
newmains avenue
inchinnan business park
renfrewshire, PA4 9-RR
UK   PA4 9RR
MDR Report Key10312145
MDR Text Key242660935
Report Number9612515-2020-00006
Device Sequence Number1
Product Code DSY
UDI-Device Identifier05037881106359
UDI-Public05037881106359
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
K060142
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 06/26/2020,07/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2022
Device Model NumberPLEXUS
Device Catalogue Number73301088/8
Device Lot Number17076229
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date06/23/2020
Device Age2 YR
Event Location Hospital
Date Report to Manufacturer06/26/2020
Initial Date Manufacturer Received 06/26/2020
Initial Date FDA Received07/23/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/30/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
-
-